News | May 05, 2022
Israeli researchers warn about the return of Delta variant
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The facility is among 12 centres established worldwide, and the first in Asia
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Glenmark Pharmaceuticals won Innovation of the Year award
Subscribe To Our Newsletter & Stay Updated
